This site is intended for healthcare professionals
Trachea Cells under the Microscope

Accreditation assessment: LOPD symposium

Supported by Amicus Therapeutics
Last updated: 24th Feb 2025
Published: 24th Feb 2025
1. Which of the following does not contribute to the diagnostic delay experienced by people with LOPD?
2. Pompe disease extends beyond a muscular disorder, affecting multiple facets of an individual’s life. Which of the following is not impacted by Pompe disease?
3. The accumulation of which molecule in the central nervous system leads to neuromuscular dysfunction associated with Pompe disease?
4. Of the following, what is the most common cause of death for people with LOPD?
5. How likely is it that you will adjust the way in which you provide enzyme replacement therapy to your patients after this symposium?
6. How likely is it that you will adjust the way in which you assess the individual needs of LOPD patients after this symposium?
7. How likely is it that you will adjust the way in which you diagnose LOPD after this symposium?
8. How likely is it that you will adjust the way you manage LOPD-related pain?
9. Would you be willing to give us further input on your perceptions and experience of this accredited activity in a follow-up 15–20-minute interview?

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.

Jointly Accredited Provider

Developed independently by EPG Health, which received educational funding from Amicus Therapeutics, Inc. awarded to EPG Health to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MEDTHORITY. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Amedco Joint Accreditation #4008163.

Professions in scope for this activity are listed below.

Physicians
Amedco LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.